CE-certified hyaluronic acid filler with 24mg/ml cross-linked HA and 3mg/ml lidocaine. Features BDDE cross-linking technology achieving ＜0.0015 IU/mg endotoxin levels (100× below EU standards). Clinically proven 9-12 month longevity with 92.7% patient satisfaction in elasticity retention (2023 KFDA data). Ideal for multi-layer facial rejuvenation from superficial rhytids to deep volumization.

CLINICAL ADVANTAGES

CROSS-LINKING INNOVATION

CLINICAL CONFIGURATIONS

PROTOCOL FOR PRACTITIONERS

*For licensed medical professionals only. Contains lidocaine – confirm patient allergy history. Not for vascular danger zones. Compliance with local medical device regulations required. Results may vary based on injection depth (recommended 2.5-4.5mm), patient metabolism, and technique. Batch-specific expiry dates apply.